RASSF1 and lung carcinoma: In nearly 50% of the stage III lung cancer patients a marked increase in RASSF1A expression was noted, which may suggest that RASSF1Ahigh lung cancers are particularly aggressive and/or have a worse prognosis via regulation of HIF-1α and metabolic switch.